圣诺生物
(688117)
| 流通市值：52.73亿 | | | 总市值：52.73亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 507,264,016.25 | 244,285,419.6 | 741,455,412.91 | 520,117,203.2 |
| 营业总成本 | 345,667,060.76 | 163,148,884.28 | 531,183,098.66 | 371,578,612.66 |
| 其他经营收益 | | | | |
| 营业利润 | 157,555,262.95 | 76,084,585.74 | 201,951,060.96 | 147,505,293.2 |
| 利润总额 | 157,375,501.09 | 75,984,043.18 | 189,129,412.34 | 145,676,073.55 |
| 净利润 | 135,194,010.21 | 66,362,232.68 | 157,889,937.35 | 126,971,331.2 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 135,194,010.21 | 66,362,232.68 | 157,889,937.35 | 126,971,331.2 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,010,202,262.47 | 948,070,383.7 | 881,428,092.52 | 865,792,254.48 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,062,142,092.12 | 1,060,376,889.3 | 1,053,099,609.05 | 1,043,354,663.71 |
| 资产总计 | 2,072,344,354.59 | 2,008,447,273 | 1,934,527,701.57 | 1,909,146,918.19 |
| 流动负债: | | | | |
| 流动负债合计 | 512,956,171.33 | 446,756,664.09 | 626,516,774.7 | 594,511,186.62 |
| 非流动负债: | | | | |
| 非流动负债合计 | 415,454,715.56 | 436,998,685.76 | 250,414,909.06 | 282,725,472.61 |
| 负债合计 | 928,410,886.89 | 883,755,349.85 | 876,931,683.76 | 877,236,659.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,143,933,467.7 | 1,124,691,923.15 | 1,057,596,017.81 | 1,031,910,258.96 |
| 股东权益合计 | 1,143,933,467.7 | 1,124,691,923.15 | 1,057,596,017.81 | 1,031,910,258.96 |
| 负债和股东权益合计 | 2,072,344,354.59 | 2,008,447,273 | 1,934,527,701.57 | 1,909,146,918.19 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 492,452,840.24 | 203,902,415.43 | 826,250,936.6 | 553,587,576.31 |
| 经营活动现金流出小计 | 405,227,170.76 | 226,026,384.68 | 647,804,939.62 | 493,485,471.1 |
| 经营活动产生的现金流量净额 | 87,225,669.48 | -22,123,969.25 | 178,445,996.98 | 60,102,105.21 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 176,314,240.16 | 26,064,791.91 | 144,033,183.68 | 94,960,038.04 |
| 投资活动现金流出小计 | 304,001,326.98 | 131,971,266.65 | 334,436,800.49 | 282,741,249.95 |
| 投资活动产生的现金流量净额 | -127,687,086.82 | -105,906,474.74 | -190,403,616.81 | -187,781,211.91 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 341,000,000 | 168,000,000 | 526,985,460.82 | 411,405,460.82 |
| 筹资活动现金流出小计 | 313,524,833.44 | 110,132,190.03 | 466,658,983.34 | 265,373,208.25 |
| 筹资活动产生的现金流量净额 | 27,475,166.56 | 57,867,809.97 | 60,326,477.48 | 146,032,252.57 |
| 汇率变动对现金及现金等价物的影响 | -1,807,014.64 | -737,838.6 | -762,029.61 | -905,097.76 |
| 现金及现金等价物净增加额 | -14,793,265.42 | -70,900,472.62 | 47,606,828.04 | 17,448,048.11 |
| 期末现金及现金等价物余额 | 238,296,336.68 | 210,151,897.72 | 253,089,602.1 | 222,930,822.17 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -14,793,265.42 | - | 47,606,828.04 | - |
最新报告期：2026-06-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信证券 | 陈竹,王凯旋 | 1.31 | 1.59 | 1.85 | 2026-06-01 |